Literature DB >> 24667915

Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex.

Kahlilia C Morris-Blanco1, Charles H Cohan1, Jake T Neumann2, Thomas J Sick3, Miguel A Perez-Pinzon1.   

Abstract

Preserving mitochondrial pools of nicotinamide adenine dinucleotide (NAD) or nicotinamide phosphoribosyltransferase (Nampt), an enzyme involved in NAD production, maintains mitochondrial function and confers neuroprotection after ischemic stress. However, the mechanisms involved in regulating mitochondrial-localized Nampt or NAD have not been defined. In this study, we investigated the roles of protein kinase C epsilon (PKCɛ) and AMP-activated protein kinase (AMPK) in regulating mitochondrial pools of Nampt and NAD after resveratrol or ischemic preconditioning (IPC) in the cortex and in primary neuronal-glial cortical cultures. Using the specific PKCɛ agonist ψɛRACK, we found that PKCɛ induced robust activation of AMPK in vitro and in vivo and that AMPK was required for PKCɛ-mediated ischemic neuroprotection. In purified mitochondrial fractions, PKCɛ enhanced Nampt levels in an AMPK-dependent manner and was required for increased mitochondrial Nampt after IPC or resveratrol treatment. Analysis of intrinsic NAD autofluorescence using two-photon microscopy revealed that PKCɛ modulated NAD in the mitochondrial fraction. Further assessments of mitochondrial NAD concentrations showed that PKCɛ has a key role in regulating the mitochondrial NAD(+)/nicotinamide adenine dinucleotide reduced (NADH) ratio after IPC and resveratrol treatment in an AMPK- and Nampt-dependent manner. These findings indicate that PKCɛ is critical to increase or maintain mitochondrial Nampt and NAD after pathways of ischemic neuroprotection in the brain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24667915      PMCID: PMC4050248          DOI: 10.1038/jcbfm.2014.51

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

Review 1.  Mechanisms of ischemic brain damage.

Authors:  Kristian P Doyle; Roger P Simon; Mary P Stenzel-Poore
Journal:  Neuropharmacology       Date:  2008-01-25       Impact factor: 5.250

Review 2.  Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?

Authors:  Ulrich Dirnagl; Andreas Meisel
Journal:  Neuropharmacology       Date:  2008-03-08       Impact factor: 5.250

3.  Preventing NAD(+) depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction.

Authors:  Dong Liu; Michael Pitta; Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

4.  epsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus.

Authors:  Ami P Raval; Kunjan R Dave; R Anthony DeFazio; Miguel A Perez-Pinzon
Journal:  Brain Res       Date:  2007-10-05       Impact factor: 3.252

Review 5.  NAD+ and NADH in ischemic brain injury.

Authors:  Weihai Ying
Journal:  Front Biosci       Date:  2008-01-01

6.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt.

Authors:  Marcella Fulco; Yana Cen; Po Zhao; Eric P Hoffman; Michael W McBurney; Anthony A Sauve; Vittorio Sartorelli
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

7.  Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair.

Authors:  Suping Wang; Zili Xing; Peter S Vosler; Hannah Yin; Wenjin Li; Feng Zhang; Armando P Signore; R Anne Stetler; Yanqin Gao; Jun Chen
Journal:  Stroke       Date:  2008-07-10       Impact factor: 7.914

8.  Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon.

Authors:  Kunjan R Dave; R Anthony DeFazio; Ami P Raval; Alessandra Torraco; Isabel Saul; Antoni Barrientos; Miguel A Perez-Pinzon
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

9.  Preconditioning mediated by sublethal oxygen-glucose deprivation-induced cyclooxygenase-2 expression via the signal transducers and activators of transcription 3 phosphorylation.

Authors:  Eun J Kim; Ami P Raval; Miguel A Perez-Pinzon
Journal:  J Cereb Blood Flow Metab       Date:  2008-04-09       Impact factor: 6.200

10.  Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts.

Authors:  Manuel Mayr; David Liem; Jun Zhang; Xiaohai Li; Nuraly K Avliyakulov; Jeong In Yang; Glen Young; Tom M Vondriska; Christophe Ladroue; Basetti Madhu; John R Griffiths; Aldrin Gomes; Qingbo Xu; Peipei Ping
Journal:  J Mol Cell Cardiol       Date:  2008-10-26       Impact factor: 5.000

View more
  30 in total

Review 1.  Resveratrol neuroprotection in stroke and traumatic CNS injury.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2015-08-12       Impact factor: 3.921

2.  Subcellular NAMPT-mediated NAD+ salvage pathways and their roles in bioenergetics and neuronal protection after ischemic injury.

Authors:  Xiaowan Wang; Zhe Zhang; Nannan Zhang; Hailong Li; Li Zhang; Christopher P Baines; Shinghua Ding
Journal:  J Neurochem       Date:  2019-10-16       Impact factor: 5.372

Review 3.  Signaling pathways leading to ischemic mitochondrial neuroprotection.

Authors:  John W Thompson; Srinivasan V Narayanan; Kevin B Koronowski; Kahlilia Morris-Blanco; Kunjan R Dave; Miguel A Perez-Pinzon
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

4.  Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

5.  Ischemic preconditioning treatment of astrocytes transfers ischemic tolerance to neurons.

Authors:  Srinivasan V Narayanan; Miguel A Perez-Pinzon
Journal:  Cond Med       Date:  2017-12

6.  Ischemic Neuroprotectant PKCε Restores Mitochondrial Glutamate Oxaloacetate Transaminase in the Neuronal NADH Shuttle after Ischemic Injury.

Authors:  Jing Xu; Nathalie Khoury; Charles W Jackson; Iris Escobar; Samuel D Stegelmann; Kunjan R Dave; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2019-08-31       Impact factor: 6.829

7.  Long-term window of ischemic tolerance: An evolutionarily conserved form of metabolic plasticity regulated by epigenetic modifications?

Authors:  Nathalie Khoury; Kevin B Koronowski; Miguel A Perez-Pinzon
Journal:  J Neurol Neuromedicine       Date:  2016

8.  Neuroprotective effects of P7C3 against spinal cord injury in rats.

Authors:  Fei-Xiang Duan; Yu-Jiao Shi; Jing Chen; Shu-Qin Ding; Feng-Chao Wang; Jie Tang; Rui Wang; Lin Shen; Jin Xi; Qi Qi; He-Zuo Lü; Jian-Guo Hu
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-13

9.  Regulation of gene expression in ischemic preconditioning in the brain.

Authors:  Tuo Yang; Qianqian Li; Feng Zhang
Journal:  Cond Med       Date:  2017-12-15

Review 10.  Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.

Authors:  Yi-Chao Hsu; Yu-Ting Wu; Chia-Ling Tsai; Yau-Huei Wei
Journal:  Exp Biol Med (Maywood)       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.